Jupiter Asset Management LTD Intercept Pharmaceuticals, Inc. Transaction History

Jupiter Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$9.17 - $19.29 $294,301 - $619,093	32,094 Added 7.28%	472,847 $5.23 Million
Q1 2023 May 10, 2023	BUY	$12.53 - $21.71 $240,049 - $415,920	19,158 Added 4.54%	440,753 $5.92 Million
Q4 2022 Feb 10, 2023	BUY	$11.61 - $16.11 $916,655 - $1.27 Million	78,954 Added 23.04%	421,595 $5.22 Million
Q3 2022 Nov 10, 2022	BUY	$12.21 - $19.7 $184,224 - $297,233	15,088 Added 4.61%	342,641 $4.78 Million
Q2 2022 Aug 10, 2022	BUY	$11.23 - $19.59 $116,129 - $202,580	10,341 Added 3.26%	327,553 $4.52 Million

Q1 2022 May 11, 2022	BUY	$13.37 - $17.79 $4.24 Million - $5.64 Million	317,212 New	317,212 $5.15 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.